KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $369.8 million.

  • Bausch Health Companies' Shares Outstanding (Weighted Average) rose 0.73% to $369.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.8 million, marking a year-over-year increase of 0.73%. This contributed to the annual value of $367.8 million for FY2024, which is 0.71% up from last year.
  • Per Bausch Health Companies' latest filing, its Shares Outstanding (Weighted Average) stood at $369.8 million for Q3 2025, which was up 0.07% from $369.6 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Shares Outstanding (Weighted Average) high stood at $369.8 million for Q3 2025, and its period low was $355.6 million during Q1 2021.
  • Over the past 3 years, Bausch Health Companies' median Shares Outstanding (Weighted Average) value was $366.8 million (recorded in 2024), while the average stood at $366.3 million.
  • Data for Bausch Health Companies' Shares Outstanding (Weighted Average) shows a peak YoY increased of 1.18% (in 2021) over the last 5 years.
  • Bausch Health Companies' Shares Outstanding (Weighted Average) (Quarterly) stood at $359.3 million in 2021, then climbed by 0.71% to $361.9 million in 2022, then increased by 0.92% to $365.2 million in 2023, then increased by 0.71% to $367.8 million in 2024, then climbed by 0.73% to $369.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $369.8 million in Q3 2025, compared to $369.6 million in Q2 2025 and $367.9 million in Q1 2025.